Anesthetic Risk and Informed Consent in Veterinary Medicine

Preoperative Health Status and Anesthetic Risk Assessment

Preoperative risk assessment is a vital clinical tool used to identify animals at elevated risk of anesthetic-related morbidity and mortality prior to procedure initiation and through the 24−7224 - 72\,h post-anesthetic period.

The American Society of Anesthesiologists (ASA) Physical Status Classification system is the standard framework used to categorize patient systemic health:

Category / ASA Status

Physical Status Description

Clinical Examples

ASA 1

Normal healthy patients with no discernible disease.

Ovariohysterectomy, ear trim, caudectomy, or elective castration.

ASA 2

Patients with mild systemic disease.

Skin tumor, bone fracture without shock, uncomplicated hernia, cryptorchidectomy, localized infection, or compensated cardiac disease.

ASA 3

Patients with severe systemic disease.

Severe fever, dehydration, anemia, cachexia, or moderate hypovolemia.

ASA 4

Patients with severe systemic disease that is a constant threat to life.

Uremia, toxemia, severe dehydration with hypovolemia, severe anemia, cardiac decompensation, emaciation, or high fever.

ASA 5

Moribund patients not expected to survive 2424\,h (11\,day) with or without operation.

Extreme shock and dehydration, terminal malignancy, terminal infection, or severe traumatic injury.

ASA Physical Status Classification Table

Anesthetic Morbidity in Small Animals

Anesthetic morbidity refers to any non-fatal disease, complication, or adverse effect resulting directly from anesthesia or the associated surgical/diagnostic procedure. The reported small animal morbidity risk in clinical practice ranges from 2%2\% to 10%10\%. Consistently detecting and documenting morbid events is difficult in veterinary practice due to superficial monitoring standards; unless a complication visibly disturbs the patient, it frequently goes unnoticed.

The Big Five Anesthetic Complications

The Big Five Anesthetic Complications

  1. Hypoxemia

  2. Hypotension

  3. Hypothermia

  4. Bradycardia

  5. Increased Nociception

Causes of hypoxemia under anesthesia

Etiology and Pathophysiology of Hypoxemia

Hypoxemia leads directly to tissue hypoxia. Five primary physiological causes account for perioperative hypoxemia:

  • Hypoventilation: The most common cause of hypoxemia under general anesthesia. Preoxygenation before induction presaturates blood arterial oxygen saturation (SpO2\text{SpO}_2) above 100%100\% to compensate for post-induction hypoventilation.

  • Right-to-Left (R > L) Shunts: Characterized by persistent perfusion of capillary beds lacking ventilation.

  • Ventilation-Perfusion (V/Q\text{V/Q}) Mismatch: Normal V/Q\text{V/Q} ratio should be close to 11, though an ideal match is impossible. Anesthetic agents exacerbate V/Q\text{V/Q} mismatching.

  • Positional Lung Compression: In dorsal recumbency, the stomach and abdominal viscera physically compress the lungs, compromising ventilation.

  • Low Inspired Oxygen Concentration (FiO2\text{FiO}_2).

Incidence of Complications by Organ System

Small Animal Anesthetic Morbidity - Respiratory and Cardiovascular SystemsSmall Animal Anesthetic Morbidity - Gastrointestinal, Thermoregulatory, Neurologic, and Recovery Systems
Respiratory System Complications
  • Depression / Apnea / Intubation Difficulty: Reported at 0.54%0.54\% in dogs and 0.34%0.34\% in cats in primary practice settings.

  • Hypoventilation / Hypercapnia (CO2>55\text{CO}_2 > 55\,mmHg): Observed in 1.3%1.3\% of dogs and 0.15%0.15\% of cats in teaching hospital environments.

  • Hypoxaemia (PaO2<60\text{PaO}_2 < 60\,mmHg or SaO2<90%\text{SaO}_2 < 90\%): Occurs in 0.5%0.5\% of dogs in teaching hospitals.

  • Severe Hypoventilation (Minute ventilation <100< 100\,mL/kg/min): Affects >60%> 60\% of dogs in veterinary school settings.

  • Hypoxaemia (SpO2<90%\text{SpO}_2 < 90\%): Affects 16%16\% of dogs in veterinary school settings.

Cardiovascular System Complications
  • Bradycardia: Reported at 0.62%0.62\% in dogs and 0.14%0.14\% in cats in primary practice settings; severe bradycardia (<50< 50\,bpm) reaches ∼36%\sim 36\% in dogs in veterinary school studies.

  • Hypotension: Defined as Systolic Arterial Pressure (SAP\text{SAP}) <80< 80\,mmHg or Mean Arterial Pressure (MAP\text{MAP}) <60< 60\,mmHg; reported in 7%7\% of dogs and 8.5%8.5\% of cats in teaching hospitals, reaching ∼38%\sim 38\% in veterinary school studies.

  • Arrhythmias: Present in 2.5%−4%2.5\% - 4\% of dogs and 1.8%−3.6%1.8\% - 3.6\% of cats in teaching hospitals.

Gastrointestinal System Complications
  • Regurgitation (without predisposing disease): Frequency ranges from 0.42%0.42\% to 0.74%0.74\%, and up to 5.5%5.5\% in select populations.

  • Postoperative Regurgitation: Affects 1.9%1.9\% of geriatric dogs.

  • Gastro-oesophageal Reflux: Ranges from 16%−17%16\% - 17\%, reaching up to 27%−60%27\% - 60\% across studies.

Thermoregulatory System Complications
  • Hypothermia: Occurs in 85%85\% of dogs (<37.3∘C< 37.3^\circ\text{C}) and 51%51\% of cats (<35.0∘C< 35.0^\circ\text{C}) in teaching hospital environments; >70%> 70\% of cats and 32%32\% of dogs (<36.5∘C< 36.5^\circ\text{C}) in veterinary schools; and 36%36\% of dogs and cats (<36.0∘C< 36.0^\circ\text{C}) in interventional trials.

Neurologic System Complications
  • Post-anaesthetic Cortical Blindness in Cats: Documented in clinical case reports; the use of spring-loaded mouth gags was noted in 1616 out of 2020 (80%80\%) affected cats, likely due to maxillary artery compression reducing cerebral perfusion during prolonged mouth opening.

Recovery and Other Complications
  • Prolonged or Poor Recovery: Occurs in 0.14%−0.18%0.14\% - 0.18\% of dogs and cats.

  • Excitement, Collapse, Reduced Consciousness, and Acute Renal Failure: Occasional occurrence.

Cardiorespiratory Complication Review in Dogs (Redondo et al., 2007)

A retrospective review of 1,2811,281 canine anesthesias documented the following complication frequencies:

  • Hypoventilation: 63.4%63.4\%

  • Hypotension: 37.9%37.9\%

  • Bradycardia: 36.3%36.3\%

  • Hypoxia: 16.4%16.4\%

  • Hypothermia: 4.8%4.8\%

  • Death: 0.9%0.9\%

Anesthetic Morbidity in Large Animals

Large Animal Anesthetic Morbidity

Equine anesthesia carries distinct morbidity patterns, with post-anesthetic musculoskeletal and neuromuscular injuries representing significant risks:

  • Cardiovascular Complications: Hypotension, second-degree atrioventricular (2∘2^\circ AV) block, atrial fibrillation (AF), and ventricular premature contractions (VPCs).

  • Respiratory Complications: Hypoventilation, hypercapnia, and hypoxemia. Combined cardiovascular and respiratory complications represent 36%36\% of all non-fatal complications (France, 2019 data).

  • Neuromuscular and Musculoskeletal Complications:

    • Non-fatal myopathy, neuropathy, and traumatic wounds account for 47%47\% of non-fatal complications.

    • Fractures occurring during recovery account for 19%−25%19\% - 25\% of all anesthetic deaths or euthanasias (CEPEF data: 25%25\%\, Kentucky data: 19%19\%).

    • Post-anesthetic myopathy/neuropathy accounts for 7%7\% of total deaths.

    • Central Nervous System (CNS) complications account for 5.5%5.5\% of deaths.

  • Gastrointestinal Complications: Post-anaesthetic colic occurs in ∼5%\sim 5\% of cases in the UK, 8%−10%8\% - 10\% within 77\,days post-procedure, and 2.5%2.5\% following elective procedures.

Anesthetic Mortality and Epidemiological Studies in Small Animals

Anesthetic mortality represents death directly resulting from anesthesia or associated procedures. Comparative mortality ratios across species highlight distinct risk profiles:

  • Humans: ∼1:10,000\sim 1:10,000 (0.01%0.01\%

  • Dogs: ∼1:588\sim 1:588 (0.17%0.17\%

  • Cats: ∼1:417\sim 1:417 (0.24%0.24\%

  • Equines: ∼1:100\sim 1:100 (1.0%−1.89%1.0\% - 1.89\%

Historical timeline of small animal anesthetic mortality studies

Historical Small Animal Anesthetic Mortality Rates

  • 1946–1950 (Angell Memorial AH, US): Dogs 0.26%0.26\%, Cats 0.36%0.36\%

  • 1955–1957 (CSU, US): Dogs 1.08%1.08\%, Cats 1.79%1.79\%

  • 1960–1969 (Wheatridge AH, US): Dogs 0.23%0.23\%, Cats 0.40%0.40\%

  • 1968–1969 (Univ. Missouri, US): Dogs 0.80%0.80\%, Cats 0.53%0.53\%

  • 1979–1981 (CSU, US): Dogs 0.43%0.43\%, Cats 0.26%0.26\%

  • 1993–1994 (CSU, US): Dogs 0.43%0.43\%, Cats 0.35%0.35\%

  • 1995–1996 (LSU, US): Dogs 1.49%1.49\%, Cats 5.80%5.80\%

  • 1999–2002 (RVC, UK): Dogs 0.58%0.58\%

  • 2002–2004 (UK Primary Practice, CEPSAF): Dogs 0.17%0.17\%, Cats 0.24%0.24\%

  • 2007–2008 (Spain Primary Practice): Small animals 1.39%1.39\%

  • 2008–2010 (France Referral Practice): Small animals 1.35%1.35\%

  • 2010–2013 (US Primary Practice): Dogs 0.05%0.05\%, Cats 0.11%0.11\%

  • 2010–2016 (US Spay-Neuter Clinic): Dogs 0.009%0.009\%, Cats 0.05%0.05\%

CEPSAF Study Analysis (Brodbelt et al., 2008)

The Confidential Enquiry into Perioperative Small Animal Fatalities (CEPSAF) evaluated risk across 98,03698,036 dogs, 79,17879,178 cats, and exotic small mammals:

  • Canine Mortality: 163163 fatalities out of 98,03698,036 (0.17%0.17\%, 95%95\% CI: 0.14%−0.19%0.14\% - 0.19\%

  • Feline Mortality: 189189 fatalities out of 79,17879,178 (0.24%0.24\%, 95%95\% CI: 0.20%−0.27%0.20\% - 0.27\%

  • Exotic & Small Mammal Mortality Rates:

    • Rabbits: 114/8,209114 / 8,209 (1.39%1.39\%, 95%95\% CI: 1.14%−1.64%1.14\% - 1.64\%

    • Guinea Pigs: 49/1,28849 / 1,288 (3.80%3.80\%, 95%95\% CI: 2.76%−4.85%2.76\% - 4.85\%

    • Ferrets: 2/6012 / 601 (0.33%0.33\%, 95%95\% CI: 0.04%−1.20%0.04\% - 1.20\%

    • Hamsters: 9/2469 / 246 (3.66%3.66\%, 95%95\% CI: 1.69%−6.83%1.69\% - 6.83\%

    • Chinchillas: 11/33411 / 334 (3.29%3.29\%, 95%95\% CI: 1.38%−5.21%1.38\% - 5.21\%

    • Rats: 8/3988 / 398 (2.01%2.01\%, 95%95\% CI: 0.87%−3.92%0.87\% - 3.92\%

    • Budgerigars: 8/498 / 49 (16.33%16.33\%, 95%95\% CI: 7.32%−29.66%7.32\% - 29.66\%

    • Parrots: 5/1275 / 127 (3.94%3.94\%, 95%95\% CI: 1.29%−8.95%1.29\% - 8.95\%

    • Reptiles: 2/1342 / 134 (1.49%1.49\%, 95%95\% CI: 0.18%−5.29%0.18\% - 5.29\%

CEPSAF Anesthetic mortality risk by health status in dogs and cats
Stratification by Health Status (CEPSAF)
  • Dogs:

    • Healthy (ASA 1–2): 49/90,61849 / 90,618 (0.05%0.05\%, ∼1:1,849\sim 1:1,849

    • Sick (ASA 3–5): 99/7,41899 / 7,418 (1.33%1.33\%, ∼1:7\sim 1:7

  • Cats:

    • Healthy (ASA 1–2): 81/72,47381 / 72,473 (0.11%0.11\%, ∼1:895\sim 1:895

    • Sick (ASA 3–5): 94/6,70594 / 6,705 (1.40%1.40\%, ∼1:8\sim 1:8

  • Rabbits:

    • Healthy (ASA 1–2): 56/7,65256 / 7,652 (0.73%0.73\%

    • Sick (ASA 3–5): 41/55741 / 557 (7.37%7.37\%

Primary causes of death in dogs, cats, and rabbits
Primary Causes of Death (CEPSAF)
  • Cardiovascular Causes: Dogs 34%34\% (2323 deaths), Cats 11%11\% (66 deaths), Rabbits 3%3\% (33 deaths). Cardiovascular complications account overall for 30%−70%30\% - 70\% of deaths (relative anesthetic overdose, myocardial depression, severe arrhythmias, circulatory collapse, hypovolemia).

  • Respiratory Causes: Dogs 20%20\% (1313 deaths), Cats 16%16\% (99 deaths), Rabbits 13%13\% (1313 deaths). Respiratory complications account for 30%−40%30\% - 40\% of deaths in dogs and 40%−50%40\% - 50\% in cats (intubation complications, physical airway obstruction).

  • Combined Cardiovascular or Respiratory Causes: Dogs 55%55\% (3737 deaths), Cats 99%99\% (5757 deaths), Rabbits 22%22\% (2323 deaths).

  • Neurological Causes: Dogs 7%7\% (55 deaths), Cats 8%8\% (55 deaths), Rabbits 2%2\% (22 deaths).

  • Renal Causes: Dogs 1%1\% (11 death), Cats 6%6\% (33 deaths), Rabbits 0%0\%

  • Unknown Causes: Dogs 31%31\% (2121 deaths), Cats 35%35\% (2020 deaths), Rabbits 57%57\% (5959 deaths); unmonitored recovery significantly contributes to unexplained deaths.

Timing of perioperative death in dogs, cats, and rabbits
Timing of Perioperative Deaths (CEPSAF)
  • Pre-medication: Dogs 1%1\% (11\, Cat 2%2\% (11\, Rabbit 0%0\%

  • Induction: Dogs 9%9\% (66\, Cats 14%14\% (88\, Rabbits 6%6\% (66

  • Maintenance: Dogs 68%68\% (4646\, Cats 53%53\% (3030\, Rabbits 29%29\% (3030

  • Postoperative Period: Dogs 70%70\% (4747\, Cats 106%106\% (6161\, Rabbits 62%62\% (6464

    • 0−30 - 3\,h Postoperative: Dogs 3131, Cats 6666, Rabbits 2626 (The majority of postoperative deaths occur within 3 hours of procedure end).

    • 3−63 - 6\,h Postoperative: Dogs 1111, Cats 99, Rabbits 77

    • 6−126 - 12\,h Postoperative: Dogs 1212, Cats 77, Rabbits 1313

    • 12−2412 - 24\,h Postoperative: Dogs 1313, Cats 1212, Rabbits 99

    • 24−4824 - 48\,h Postoperative: Dogs 33, Cats 1010, Rabbits 33

Global Risk and Protective Factors in Small Animals

Risk and protective factors summary in dogs and catsCEPSAF multivariable risk factor model for cats

CEPSAF Multivariable Model for Feline Mortality

  • Health Status (ASA Grade): Odds Ratio (OR) 3.23.2 per category increase (95%95\% CI: 2.0−5.02.0 - 5.0, p<0.001p < 0.001

  • Urgency: Emergency vs. urgent vs. scheduled OR 1.61.6 (95%95\% CI: 1.0−2.51.0 - 2.5, p=0.050p = 0.050

  • Procedure Type: Major procedure vs. minor procedure OR 2.72.7 (95%95\% CI: 1.4−5.41.4 - 5.4, p=0.005p = 0.005

  • Weight: Body weight 0−20 - 2\,kg OR 15.715.7 (95%95\% CI: 2.9−83.62.9 - 83.6, p=0.002p = 0.002\, weight 66\,kg–max OR 2.82.8 (95%95\% CI: 1.1−7.41.1 - 7.4

  • Endotracheal Intubation: Presence of ET tube OR 1.91.9 (95%95\% CI: 1.0−3.71.0 - 3.7, p=0.042p = 0.042

  • Monitoring: Pulse assessment + Pulse oximetry OR 0.20.2 (95%95\% CI: 0.1−0.40.1 - 0.4, p<0.001p < 0.001

  • Perioperative IV Fluids: Intravenous fluids given OR 3.93.9 (95%95\% CI: 2.2−7.12.2 - 7.1, p<0.001p < 0.001

Global Canine Anesthetic Mortality (Redondo et al., 2024)

An international prospective study evaluating 55,02255,022 dogs across 405405 centers reported an overall mortality of 0.69%0.69\% (1:1451:145). Postoperative deaths accounted for 81%81\% of all fatalities.

Multivariable logistic regression odds ratios for anesthetic mortality in dogsTimeline of perioperative mortality in dogs
Logistic Regression Odds Ratios in Dogs
  • Age Categories: Paediatric (<0.25< 0.25\,yr) OR 4.214.21 (p=0.012p = 0.012\, Geriatric (>12> 12\,yr) OR 1.671.67 (p=0.018p = 0.018

  • Body Condition Score (BCS): Obese (BCS 5/5) OR 2.282.28 (p=0.003p = 0.003

  • ASA Status: ASA II OR 3.063.06 (p=0.009p = 0.009\, ASA III OR 12.0612.06 (p<0.001p < 0.001\, ASA IV OR 57.7057.70 (p<0.001p < 0.001\, ASA V OR 167.74167.74 (p<0.001p < 0.001

  • Procedure Urgency: Non-scheduled OR 1.611.61 (p=0.011p = 0.011\, Emergency OR 1.641.64 (p=0.008p = 0.008

  • Surgical Category: Abdominal OR 1.621.62 (p=0.011p = 0.011\, Orthopaedics OR 2.172.17 (p=0.002p = 0.002\, Thoracic OR 2.192.19 (p=0.012p = 0.012

  • Procedure Duration: Short duration OR 3.703.70 (p<0.001p < 0.001

  • Premedication Protective Factors: Alpha-2 agonist OR 0.690.69 (p=0.014p = 0.014\, Acepromazine OR 0.410.41 (p=0.038p = 0.038

  • Preoperative Analgesia Protective Factors: Opioid partial agonist/antagonist + NSAIDs OR 0.230.23 (p=0.046p = 0.046\, Opioid pure OR 0.630.63 (p=0.003p = 0.003\, Opioid pure + NSAIDs OR 0.110.11 (p=0.002p = 0.002

  • Maintenance Agent Protective Factors: Sevoflurane OR 0.510.51 (p=0.001p = 0.001

  • Locoregional Anesthesia: Presence of locoregional block OR 0.620.62 (p=0.001p = 0.001

Canine Mortality Phase Breakdown
  • Induction: 6%6\%

  • Maintenance: 13%13\%

  • Recovery in OR: 11%11\%

  • Post-op 0−30 - 3\,h: 13%13\%

  • Post-op 3−63 - 6\,h: 13%13\%

  • Post-op 6−246 - 24\,h: 25%25\%

  • Post-op 24−4824 - 48\,h: 19%19\%

Global Feline Anesthetic Mortality (Redondo et al., 2024)

An international study evaluating 14,96214,962 cats across 198198 centers reported an overall mortality of 0.63%0.63\% (1:1591:159), with 74.5%74.5\% occurring postoperatively.

Treemap of cat breed distribution in global studyMultivariable logistic regression odds ratios for anesthetic mortality in cats
Logistic Regression Odds Ratios in Cats
  • Body Condition Score: Cachectic (BCS 1/5) OR 5.655.65 (p<0.001p < 0.001

  • ASA Status: ASA 2 OR 8.768.76 (p=0.046p = 0.046\, ASA 3 OR 28.5728.57 (p=0.002p = 0.002\, ASA 4 OR 145.67145.67 (p<0.001p < 0.001\, ASA 5 OR 814.44814.44 (p<0.001p < 0.001

  • Surgical Category: Abdominal OR 2.542.54 (p=0.025p = 0.025\, Orthopaedics OR 3.103.10 (p=0.025p = 0.025\, Thoracic OR 4.044.04 (p=0.005p = 0.005

  • Mechanical Ventilation: Mechanical ventilation used OR 1.841.84 (p=0.039p = 0.039

  • Protective Factors: Alpha-2 agonist premedication OR 0.540.54 (p=0.041p = 0.041\, Pure opioid premedication OR 0.410.41 (p=0.006p = 0.006\, Locoregional techniques OR 0.600.60 (p=0.112p = 0.112

Feline Mortality Phase Breakdown
  • Induction: 6%6\%

  • Maintenance: 19%19\%

  • Recovery in OR: 14%14\%

  • Post-op 0−30 - 3\,h: 16%16\%

  • Post-op 3−63 - 6\,h: 12%12\%

  • Post-op 6−246 - 24\,h: 16%16\%

  • Post-op 24−4824 - 48\,h: 17%17\%

Special Clinical Risk Considerations: Brachycephalic Breeds

Brachycephalic breeds (e.g., English Bulldogs, French Bulldogs, Pugs, Shih-Tzus, Boston Terriers, Boxers) possess short-head cranial conformations that increase perioperative vulnerability.

Pathophysiology of Brachycephalic Airway Obstructive Syndrome (BAOS)

  • Anatomical changes include an enlarged tongue, shortened nasal bones, stenotic nares, narrowed nasal passages, elongated soft palate, and hypoplastic trachea.

  • High airway resistance forces inhalation through constricted passages, escalating negative intrathoracic pressure. Chronic pressure changes induce secondary soft tissue edema in the pharynx and larynx.

Triad of Clinical Complications

  1. Respiratory Failure: Severe dyspnea, upper airway obstruction, dynamic airway collapse, and aspiration pneumonia.

  2. Thermoregulatory Impairment: Inefficient panting severely impairs heat dissipation, creating hyperthermia risks amplified by stress and obesity.

  3. Gastrointestinal Dysfunction: Persistent negative intrathoracic pressures cause chronic gastro-esophageal reflux, regurgitation, and vomiting.

Post-Anesthetic Management Requirements

  • Leave endotracheal tubes in place until the patient is fully awake, sternal, and actively swallowing/attempting tube ejection.

  • Postoperative decompensation can trigger emergency temporary tracheostomy placement or re-intubation.

Anesthetic Mortality and Risk Factors in Large Animals

Large animal anesthesia carries a significantly higher overall mortality risk than small animal anesthesia, driven by post-anesthetic musculoskeletal trauma.

Equine Mortality Rate Progression Across CEPEF Trials

  • CEPEF 2 (2002): Overall mortality 1.89%1.89\% (∼1:53\sim 1:53\, Non-abdominal / non-emergency 0.9%0.9\% (∼1:111\sim 1:111\, Colic emergencies 7.8%7.8\% (∼1:13\sim 1:13

  • CEPEF 3 (2002): Overall mortality 1.61%1.61\% (∼1:62\sim 1:62\, Non-abdominal / non-emergency 0.9%0.9\% (∼1:111\sim 1:111

  • CEPEF 4 (Gozalo-Marcilla et al., 2025): Overall mortality 1.2%1.2\% (∼1:83\sim 1:83\, Non-abdominal / non-emergency 0.6%0.6\% (∼1:166\sim 1:166\, Colic emergencies 4.2%4.2\% (∼1:24\sim 1:24

Primary Causes of Equine Anesthetic Death

  • Cardiovascular Collapse / Arrest: Accounts for 20%−50%20\% - 50\% of deaths. CPR efficacy is minimal in adult horses, unlike small animals where CPR successfully resuscitates ∼50%\sim 50\% of cardiac arrests.

  • Respiratory Causes: Account for <25%< 25\% (and as low as 4%4\%) of deaths.

  • Non-Cardiopulmonary Causes: Account for ∼77%\sim 77\% of total deaths. Recovery fractures and post-anesthetic myopathy combined represent 50%−70%50\% - 70\% of deaths. Abdominal complications (sepsis, colitis) account for secondary post-op losses.

  • Found Dead Unknown Cause: Accounts for only ∼5%\sim 5\% of cases due to close monitoring.

Timing and Risk Factors in Horses

Postoperative recovery represents the most hazardous phase in horses (>44%> 44\% of deaths in historical CEPEF; 88%−100%88\% - 100\% in single-center studies; >85%> 85\% of non-colic deaths in CEPEF 4).

  • Increased Risk Factors: Advanced age/geriatric status, pregnancy, elevated ASA status, surgical urgency (colic), prolonged duration, elevated perioperative blood lactate, ketamine CRI, nighttime procedures (66\,pm to 66\,am due to staffing levels), and dorsal body position (dorsal position causes greater pulmonary atelectasis and V/Q\text{V/Q} mismatch than left or right lateral recumbency).

  • Decreased Risk Factors: Acepromazine (ACP) premedication, continuous direct blood pressure monitoring, end-tidal CO2\text{CO}_2 (EtCO2\text{EtCO}_2) monitoring, arterial blood gas analysis, butorphanol administration, alpha-2 agonist administration during recovery, and combined ACP + alpha-2 agonist recovery protocols.

Informed Consent, Ethical Framework, and Communication

Informed consent is the legal and ethical foundation of veterinary anesthetic care. It requires that a legal decision-maker (owner or authorized representative) receive an evidence-informed assessment of risks to make an autonomous decision.

Communication Strategies by Physical Status

  • Low ASA (Healthy Patients, ASA 1–2): Communicate that baseline risk is low but never zero, explicitly identifying the possibility of major complications or death. Detail planned monitoring protocols and supportive care, frame choices using professional recommendation ("If this were my animal…").

  • High ASA (Sick Patients, ASA 3–5): State clearly that risk of severe complications, acute decompensation, unforeseen events, and death is elevated. Focus discussion on stabilization strategies, specialized drug protocols, intensive monitoring, and supportive interventions.

Anesthesia, surgery, and treatment consent form standard template

Documentation Requirements

Consent forms must record: patient identity, owner contact information, procedure authorization, verification of pre-procedure fasting/water restrictions, vaccination history, pre-existing illnesses/medications, prior anesthetic reactions, authorization for emergency interventions, overnight supervision disclosure, and financial responsibility statements.